dimarts, 21 d’octubre del 2014

FDA reverses stance on reporting requirement | Regulatory news for the week of October 20, 2014




Here's a look at some of the top regulatory stories for medical device companies this week: FDA yanks enhancement reporting requirement; FDA approves Medtronic's full-body MRI-safe lead; FDA strikes out again in Prevor drug-or-device case; Abbott inks co-distribution deal with Carl Zeiss Meditec; Boston Scientific wins CE Mark for Accolade MRI-safe pacemakers






FDA yanks enhancement reporting requirement


October 15, 2014 by Brad Perriello




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/ZEGuNc

Cap comentari:

Publica un comentari a l'entrada